v3.25.1
Segment (Tables)
3 Months Ended
Mar. 31, 2025
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information by Segment

 

Clinical Research Segment

 

 

Three Months Ended

 

 

March 31,

 

 

2025

 

 

2024

 

 

 

 

 

 

 

 

(in thousands)

 

Operating expenses:

 

 

 

 

 

Direct program expense

$

7,872

 

 

$

5,353

 

Indirect program expense

 

526

 

 

 

517

 

Workforce salaries and benefits

 

4,407

 

 

 

3,355

 

Share-based compensation expense

 

2,745

 

 

 

107

 

General corporate expenses

 

1,450

 

 

 

499

 

Segment net loss

 

17,000

 

 

 

9,831

 

Reconciliation of loss:

 

 

 

 

 

Interest income

 

(1,075

)

 

 

(295

)

Adjustments and reconciling items

 

(1,075

)

 

 

(295

)

Net loss

$

15,925

 

 

$

9,536